Wolfgang Schima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wolfgang Schima has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Ahmed Ba-Ssalamah
4 shared publicationsA. Ba-Ssalamah
Medizinische Universität Wien
3 shared publicationsC. Kulinna-Cosentini
3 shared publications- A. Ba-Ssalamah2 shared publications
A. Püspök
Universitätsklinik für Innere Medizin 4, Medizinische Universität Wien
2 shared publicationsC. Plank
Medizinische Universität Wien
2 shared publications
Latest Publications
- 11 October 2011
- Vol. 94 (4) , 169-77
Liver metastases.
Liver metastases are a very common site of distant metastases. Detection and accurate characterization of liver metastases is of importance to guide therapy. A variety of imaging modalities such as US (including contrast agents), MDCT, MRI with liver -specific contrast agents and PET/CT are available for this purpose. This review presents imaging techniques and summarizes the current knowledge, how the different imaging modalities should be used.
- 11 October 2011
- Vol. 94 (4) , 169-77
Liver metastases.
Liver metastases are a very common site of distant metastases. Detection and accurate characterization of liver metastases is of importance to guide therapy. A variety of imaging modalities such as US (including contrast agents), MDCT, MRI with liver -specific contrast agents and PET/CT are available for this purpose. This review presents imaging techniques and summarizes the current knowledge, how the different imaging modalities should be used.
- 29 April 2011
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 183 (S 01) , VO403_3
Der Stellenwert des Hydro-Multidetektor CT für das prä-operative Staging des Magenkarzinoms
Ziele: Ziel der Studie war, den Stellenwert des Mulitdektor CT's mit Wasserfüllungs-Technik (Hydro-MDCT) in der prä-operativen Evaluierung von Magenkarzinomen, mittels der TNM Klassifikation, zu evaluieren. Methode: 133 Patienten die ein histologisch verifiziertes Magenkarzinom hatten und eine prä-operative Hydro-MDCT Untersuchung erhielten, wurden in die Studie eingeschlossen. Von diesem Patientenkollektiv erhielten 33 eine neoadjuvante Chemotherapie, der Rest erhielt keine. Bei 79 Patienten wurde eine totale Gastrektomie durchgeführt, bei 54 eine partielle Gastrektomie nach Billroth II-(53 Patienten), bzw. Billroth I (1 Patient). Als Vorbereitung auf die CT-Untersuchung durften die Patienten mind. 6 Stunden vor Untersuchungsbeginn keine feste Nahrung zu sich nehmen. 2 Stunden vor der Untersuchung wurden sie aufgefordert, bis zu 1.5 Liter Leitungswasser zu trinken um eine optimale Distension des Magens zu gewährleisten. Die Darmperistaltik wurde mittels 20mg Scopolamin i.v reduziert. Anschließend wurde 150ml nicht ionisches Kontrastmittel mit einer Injektionsgeschwindigkeit von 3–5ml/sek i.v gespritzt. Eine arterielle Phase über den Thorax und Oberbauch und eine venöse Phase über das gesamte Abdomen wurde gefahren. Die Untersuchungen fanden an 4-,16-,64- Mehrzeiler MDCT's statt. Axiale, cornale und sagittale Rekonstruktionen wurden angefertigt und von einem erfahrenen Radiologen ausgewertet. Ergebnis: Bezüglich des T-Stagings wurde eine Genauigkeit von 66.17% (88/33), bezüglich des N-Stagings, eine Genauigkeit von 53.85% (70/133) erzielt. Das häufigste pT Stadium war T2 (51.88%), gefolgt von T1(22.56%) und T3 (21.80%). Lediglich 5 Patienten hatten ein pT4 Stadium (3.76%). Die überwiegende Mehrzahl (81.95%) der Tumore waren Adenokarzinome. Die häufigste Tumorlokalisation war der Pylorus (30.07%), gefolgt von der Kardia (29.32%) und dem Korpus (24.06%). Schlussfolgerung: MDCT mit Wasserfüllung ist eine geeignete nicht invasive Technik zum präoperativen TNM Staging eines Magenkarzinoms. Keywords: Magenkarzinom, Staging, TNM, MDCT Korrespondierender Autor: Baroud S Universitätsklinik für Radiodiagnostik, Allgemeine Radiologie und Kinderradiologie, Währinger Gürtel 18–20, A-1090, Wien E-Mail: susanne.baroud@meduniwien.ac.at
- 29 April 2011
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 183 (S 01) , VO403_3
Der Stellenwert des Hydro-Multidetektor CT für das prä-operative Staging des Magenkarzinoms
Ziele: Ziel der Studie war, den Stellenwert des Mulitdektor CT's mit Wasserfüllungs-Technik (Hydro-MDCT) in der prä-operativen Evaluierung von Magenkarzinomen, mittels der TNM Klassifikation, zu evaluieren. Methode: 133 Patienten die ein histologisch verifiziertes Magenkarzinom hatten und eine prä-operative Hydro-MDCT Untersuchung erhielten, wurden in die Studie eingeschlossen. Von diesem Patientenkollektiv erhielten 33 eine neoadjuvante Chemotherapie, der Rest erhielt keine. Bei 79 Patienten wurde eine totale Gastrektomie durchgeführt, bei 54 eine partielle Gastrektomie nach Billroth II-(53 Patienten), bzw. Billroth I (1 Patient). Als Vorbereitung auf die CT-Untersuchung durften die Patienten mind. 6 Stunden vor Untersuchungsbeginn keine feste Nahrung zu sich nehmen. 2 Stunden vor der Untersuchung wurden sie aufgefordert, bis zu 1.5 Liter Leitungswasser zu trinken um eine optimale Distension des Magens zu gewährleisten. Die Darmperistaltik wurde mittels 20mg Scopolamin i.v reduziert. Anschließend wurde 150ml nicht ionisches Kontrastmittel mit einer Injektionsgeschwindigkeit von 3–5ml/sek i.v gespritzt. Eine arterielle Phase über den Thorax und Oberbauch und eine venöse Phase über das gesamte Abdomen wurde gefahren. Die Untersuchungen fanden an 4-,16-,64- Mehrzeiler MDCT's statt. Axiale, cornale und sagittale Rekonstruktionen wurden angefertigt und von einem erfahrenen Radiologen ausgewertet. Ergebnis: Bezüglich des T-Stagings wurde eine Genauigkeit von 66.17% (88/33), bezüglich des N-Stagings, eine Genauigkeit von 53.85% (70/133) erzielt. Das häufigste pT Stadium war T2 (51.88%), gefolgt von T1(22.56%) und T3 (21.80%). Lediglich 5 Patienten hatten ein pT4 Stadium (3.76%). Die überwiegende Mehrzahl (81.95%) der Tumore waren Adenokarzinome. Die häufigste Tumorlokalisation war der Pylorus (30.07%), gefolgt von der Kardia (29.32%) und dem Korpus (24.06%). Schlussfolgerung: MDCT mit Wasserfüllung ist eine geeignete nicht invasive Technik zum präoperativen TNM Staging eines Magenkarzinoms. Keywords: Magenkarzinom, Staging, TNM, MDCT Korrespondierender Autor: Baroud S Universitätsklinik für Radiodiagnostik, Allgemeine Radiologie und Kinderradiologie, Währinger Gürtel 18–20, A-1090, Wien E-Mail: susanne.baroud@meduniwien.ac.at
- 30 June 2009
- Published by Elsevier in European Journal of Radiology
- Vol. 70 (3) , 600
Colorectal cancer
- 30 June 2009
- Published by Elsevier in European Journal of Radiology
- Vol. 70 (3) , 600
Colorectal cancer
- 1 June 2009
- Published by Elsevier in European Journal of Radiology
- Vol. 70 (3) , 600-601
Book review
- 7 April 2009
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 181 (06) , 587-592
Gadoxate-Enhanced T 1-Weighted MR Cholangiography: Comparison of 1.5 T and 3.0 T
Ziel: Vergleich der Gadoxate-verstärkten T 1-gewichteten Cholangiografie bei 1,5 T und 3,0 T Feldstärke. Material und Methoden: 40 Patienten mit nicht dilatierten Gallenwegen wurden in diese retrospektive Studie eingeschlossen. Eine T 1-gewichtete MR-Cholangiografie 20 min nach i. v. Applikation von 0,025 mmol/kg Gadoxate (Primovist™) wurde bei 20 Patienten bei 1,5 T Feldstärke angefertigt. Die anderen 20 Patienten wurden bei 3,0 T Feldstärke untersucht. Das Kontrast-Rausch-Verhältnis des Gallensystems (Ductus hepatocholedochus – DHC; Ductus hepaticus dexter – DHD; Ductus hepaticus sinister – DHS) im Vergleich zum umgebenden Gewebe wurde gemessen. Darüber hinaus wurde eine qualitative Analyse von 2 Radiologen durchgeführt, wobei die Sichtbarkeit der intra- und extrahepatischen Gallenwege mittels einer 6-Punkte-Skala evaluiert wurde. Die statistische Auswertung erfolgte mittels Mann-Whitney-U-Test und Pearson-Korrelation-Koeffizient. Ergebnisse: Die Kontrast-Rausch-Verhältnisse der intra- und extrahepatischen Gallenwege waren bei 3,0 T signifikant höher als bei 1,5 T. Die qualitative Analyse zeigte eine signifikant bessere Abgrenzbarkeit der intrahepatischen Gallenwege (DHD, DHS, segmentale Gallenwege) bei 3,0 T Feldstärke. Schlussfolgerung: Die Gadoxate-verstärkte T 1-gewichtete MR-Cholangiografie bei 3,0 T ermöglicht eine bessere Darstellung der intrahepatischen Gallenwege als bei 1,5 T. Purpose: To qualitatively and quantitatively compare gadoxate-enhanced T 1-weighted MR cholangiography at magnetic field strengths of 1.5 T and 3.0 T. Materials and Methods: A total of 40 patients with a non-dilated biliary system were retrospectively included in the study. T 1-weighted MR cholangiography 20 min after IV administration of 0.025 mmol/kg gadoxate (Primovist™) was performed in 20 patients at 1.5 T and in another 20 patients at 3.0 T. Contrast-to-noise ratios (CNR) of the biliary system (common bile duct – CBD, right hepatic duct – RHD, left hepatic duct – LHD) compared to the periductal tissue were measured. Two radiologists also qualitatively assessed the visibility of the intrahepatic and extrahepatic biliary system using a six-point rating scale. The Mann-Whitney U-test and Pearson’s correlation coefficient were used for statistical analysis. Results: The CNRs of the intrahepatic and extrahepatic hepatic bile ducts were significantly higher at 3.0 T. Qualitative analysis showed a significant superiority for 3.0 T in the delineation of the intrahepatic biliary system (RHD, LHD, segmental ducts). Conclusion: Gadoxate-enhanced T 1-w MR cholangiography at 3.0 T offers better delineation of the intrahepatic biliary system in comparison to imaging at 1.5 T.
- 7 April 2009
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 181 (06) , 587-592
Gadoxate-Enhanced T 1-Weighted MR Cholangiography: Comparison of 1.5 T and 3.0 T
Ziel: Vergleich der Gadoxate-verstärkten T 1-gewichteten Cholangiografie bei 1,5 T und 3,0 T Feldstärke. Material und Methoden: 40 Patienten mit nicht dilatierten Gallenwegen wurden in diese retrospektive Studie eingeschlossen. Eine T 1-gewichtete MR-Cholangiografie 20 min nach i. v. Applikation von 0,025 mmol/kg Gadoxate (Primovist™) wurde bei 20 Patienten bei 1,5 T Feldstärke angefertigt. Die anderen 20 Patienten wurden bei 3,0 T Feldstärke untersucht. Das Kontrast-Rausch-Verhältnis des Gallensystems (Ductus hepatocholedochus – DHC; Ductus hepaticus dexter – DHD; Ductus hepaticus sinister – DHS) im Vergleich zum umgebenden Gewebe wurde gemessen. Darüber hinaus wurde eine qualitative Analyse von 2 Radiologen durchgeführt, wobei die Sichtbarkeit der intra- und extrahepatischen Gallenwege mittels einer 6-Punkte-Skala evaluiert wurde. Die statistische Auswertung erfolgte mittels Mann-Whitney-U-Test und Pearson-Korrelation-Koeffizient. Ergebnisse: Die Kontrast-Rausch-Verhältnisse der intra- und extrahepatischen Gallenwege waren bei 3,0 T signifikant höher als bei 1,5 T. Die qualitative Analyse zeigte eine signifikant bessere Abgrenzbarkeit der intrahepatischen Gallenwege (DHD, DHS, segmentale Gallenwege) bei 3,0 T Feldstärke. Schlussfolgerung: Die Gadoxate-verstärkte T 1-gewichtete MR-Cholangiografie bei 3,0 T ermöglicht eine bessere Darstellung der intrahepatischen Gallenwege als bei 1,5 T. Purpose: To qualitatively and quantitatively compare gadoxate-enhanced T 1-weighted MR cholangiography at magnetic field strengths of 1.5 T and 3.0 T. Materials and Methods: A total of 40 patients with a non-dilated biliary system were retrospectively included in the study. T 1-weighted MR cholangiography 20 min after IV administration of 0.025 mmol/kg gadoxate (Primovist™) was performed in 20 patients at 1.5 T and in another 20 patients at 3.0 T. Contrast-to-noise ratios (CNR) of the biliary system (common bile duct – CBD, right hepatic duct – RHD, left hepatic duct – LHD) compared to the periductal tissue were measured. Two radiologists also qualitatively assessed the visibility of the intrahepatic and extrahepatic biliary system using a six-point rating scale. The Mann-Whitney U-test and Pearson’s correlation coefficient were used for statistical analysis. Results: The CNRs of the intrahepatic and extrahepatic hepatic bile ducts were significantly higher at 3.0 T. Qualitative analysis showed a significant superiority for 3.0 T in the delineation of the intrahepatic biliary system (RHD, LHD, segmental ducts). Conclusion: Gadoxate-enhanced T 1-w MR cholangiography at 3.0 T offers better delineation of the intrahepatic biliary system in comparison to imaging at 1.5 T.
- 1 December 2007
- Published by Wolters Kluwer Health in Topics in Magnetic Resonance Imaging
- Vol. 18 (6) , 421-429
State-of-the-Art Magnetic Resonance Imaging of Pancreatic Cancer
Technical advances of magnetic resonance imaging (MRI), including ultrahigh-field magnetic resonance at 3.0 T, parallel imaging techniques, and multichannel receive coils of the abdomen, have promoted MRI of the pancreas. For adenocarcinoma, which is the most common malignant pancreatic tumor, helical CT has been most often used for detection and staging, but it has limitations in the detection of small cancers 2 cm in diameter or less (sensitivity, 63%). Moreover, it is not very accurate in determining nonresectability, because small liver metastases, peritoneal carcinomatosis, and subtle signs of vascular infiltration may be missed. At ultrahigh field at 3.0 T, gadolinium-enhanced MRI using volume-interpolated 3-dimensional gradient-recalled echo pulse sequences with near-isotropic voxels are very useful for detection of subtle abnormalities. Mangafodipir-enhanced MRI reveals a very high tumor-pancreas contrast, which helps to diagnose small cancers. Contrast-enhanced MRI is a problem-solving tool in case of equivocal CT: it helps to differentiate between cancer and focal pancreatitis. Neuroendocrine carcinoma may present with a spectrum of appearances at MRI, but the primary tumor and liver metastases are hypervascular in approximately 70%. In this article, pancreas imaging protocols for 1.5 and 3.0 T are explained. We present the imaging features of pancreatic cancer and the important questions in staging, which should be addressed by the radiologist.
- 1 December 2007
- Published by Wolters Kluwer Health in Topics in Magnetic Resonance Imaging
- Vol. 18 (6) , 421-429
State-of-the-Art Magnetic Resonance Imaging of Pancreatic Cancer
Technical advances of magnetic resonance imaging (MRI), including ultrahigh-field magnetic resonance at 3.0 T, parallel imaging techniques, and multichannel receive coils of the abdomen, have promoted MRI of the pancreas. For adenocarcinoma, which is the most common malignant pancreatic tumor, helical CT has been most often used for detection and staging, but it has limitations in the detection of small cancers 2 cm in diameter or less (sensitivity, 63%). Moreover, it is not very accurate in determining nonresectability, because small liver metastases, peritoneal carcinomatosis, and subtle signs of vascular infiltration may be missed. At ultrahigh field at 3.0 T, gadolinium-enhanced MRI using volume-interpolated 3-dimensional gradient-recalled echo pulse sequences with near-isotropic voxels are very useful for detection of subtle abnormalities. Mangafodipir-enhanced MRI reveals a very high tumor-pancreas contrast, which helps to diagnose small cancers. Contrast-enhanced MRI is a problem-solving tool in case of equivocal CT: it helps to differentiate between cancer and focal pancreatitis. Neuroendocrine carcinoma may present with a spectrum of appearances at MRI, but the primary tumor and liver metastases are hypervascular in approximately 70%. In this article, pancreas imaging protocols for 1.5 and 3.0 T are explained. We present the imaging features of pancreatic cancer and the important questions in staging, which should be addressed by the radiologist.
- 5 March 2007
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 25 (4) , 749-754
Dynamic MR imaging of the gastroesophageal junction in healthy volunteers during bolus passage
Purpose: To evaluate the feasibility of noninvasive dynamic fast magnetic resonance imaging (MRI) during swallowing in healthy volunteers, and to determine esophageal function at the gastroesophageal junction during swallowing.Materials and Methods: A total of 20 healthy volunteers underwent MRI while swallowing in the supine position. Dynamic gradient‐echo (GRE) sequences (balanced fast field echo [B‐FFE]) were employed in three planes on a 1.5T unit using a phased‐array body coil. Buttermilk spiked with gadolinium (Gd) chelate (40:1) for bolus passage was used as an oral contrast agent. We evaluated visualization of esophageal bolus transit, bolus transit time (BTT), peristalsis, identification of the gastroesophageal junction, and reflux during the Valsalva maneuver.Results: The mean visible length of the esophagus was 16.2 ± 5.3 cm in the sagittal view, and 13.8 ± 4.9 cm in the coronal view. In the sagittal view the BTT was defined in 15 of 20 volunteers and was 7.6 ± 1.4 seconds. The BTT in the coronal view was measured in seven of 20 volunteers and was 8 ± 1.3 seconds on average. The axial view yielded higher scores (2.25) than the coronal (1.98) and sagittal (1.78) views for identification of the cardia and during the Valsalva maneuver. Bolus contrast was better displayed in the sagittal (2.2) view than in the coronal (2.08) or axial (1.73) planes. In six volunteers, gastroesophageal abnormalities, such as axial hernia, reflux, and nonperistaltic contractions, were identified. For statistical analysis we used the Friedman test and a one‐way analysis of variance (ANOVA).Conclusion: The results indicate that dynamic MR swallowing is a feasible and reproducible technique that warrants further studies in patients. J. Magn. Reson. Imaging 2007.
- 5 March 2007
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 25 (4) , 749-754
Dynamic MR imaging of the gastroesophageal junction in healthy volunteers during bolus passage
Purpose: To evaluate the feasibility of noninvasive dynamic fast magnetic resonance imaging (MRI) during swallowing in healthy volunteers, and to determine esophageal function at the gastroesophageal junction during swallowing.Materials and Methods: A total of 20 healthy volunteers underwent MRI while swallowing in the supine position. Dynamic gradient‐echo (GRE) sequences (balanced fast field echo [B‐FFE]) were employed in three planes on a 1.5T unit using a phased‐array body coil. Buttermilk spiked with gadolinium (Gd) chelate (40:1) for bolus passage was used as an oral contrast agent. We evaluated visualization of esophageal bolus transit, bolus transit time (BTT), peristalsis, identification of the gastroesophageal junction, and reflux during the Valsalva maneuver.Results: The mean visible length of the esophagus was 16.2 ± 5.3 cm in the sagittal view, and 13.8 ± 4.9 cm in the coronal view. In the sagittal view the BTT was defined in 15 of 20 volunteers and was 7.6 ± 1.4 seconds. The BTT in the coronal view was measured in seven of 20 volunteers and was 8 ± 1.3 seconds on average. The axial view yielded higher scores (2.25) than the coronal (1.98) and sagittal (1.78) views for identification of the cardia and during the Valsalva maneuver. Bolus contrast was better displayed in the sagittal (2.2) view than in the coronal (2.08) or axial (1.73) planes. In six volunteers, gastroesophageal abnormalities, such as axial hernia, reflux, and nonperistaltic contractions, were identified. For statistical analysis we used the Friedman test and a one‐way analysis of variance (ANOVA).Conclusion: The results indicate that dynamic MR swallowing is a feasible and reproducible technique that warrants further studies in patients. J. Magn. Reson. Imaging 2007.
- Open Access
- 1 January 2007
- Published by E-MED LTD in Cancer Imaging
- Vol. 7 (Special A) , S28-S36
Post-treatment imaging of liver tumours
Post-treatment imaging of liver tumours - Cancer Imaging Post-treatment imaging of liver tumours - In the past few years, great improvements have been made to achieve local tumour control of primary liver malignancies and liver metastases. For hepatocellular carcinoma (HCC), transarterial chemoembolisation (TACE) and tumour ablation techniques, including percutaneous ethanol injection (PEI), radiofrequency ablation (RF), and laserinduced interstitial thermotherapy (LITT) have been developed. For colorectal liver metastases, surgery is still the standard technique in localised disease, although percutaneous RF ablation has gained considerable acceptance.
- 1 January 2007
- Published by E-MED LTD in Cancer Imaging
- Vol. 7 (Special A) , S28-S36
Open AccessPost-treatment imaging of liver tumours
Post-treatment imaging of liver tumours - Cancer Imaging Post-treatment imaging of liver tumours - In the past few years, great improvements have been made to achieve local tumour control of primary liver malignancies and liver metastases. For hepatocellular carcinoma (HCC), transarterial chemoembolisation (TACE) and tumour ablation techniques, including percutaneous ethanol injection (PEI), radiofrequency ablation (RF), and laserinduced interstitial thermotherapy (LITT) have been developed. For colorectal liver metastases, surgery is still the standard technique in localised disease, although percutaneous RF ablation has gained considerable acceptance.
- 6 December 2006
- Published by Springer Nature in European Radiology
- Vol. 17 (5) , 1242-1255
Artifacts in body MR imaging: their appearance and how to eliminate them
A wide variety of artifacts can be seen in clinical MR imaging. This review describes the most important and most prevalent of them, including magnetic susceptibility artifacts and motion artifacts, aliasing, chemical-shift, zipper, zebra, central point, and truncation artifacts. Although the elimination of some artifacts may require a service engineer, the radiologist and MR technologist have the responsibility to recognize MR imaging problems. This review shows the typical MR appearance of the described artifacts, explains their physical basis, and shows the way to solve them in daily practice.
- 6 December 2006
- Published by Springer Nature in European Radiology
- Vol. 17 (5) , 1242-1255
Artifacts in body MR imaging: their appearance and how to eliminate them
A wide variety of artifacts can be seen in clinical MR imaging. This review describes the most important and most prevalent of them, including magnetic susceptibility artifacts and motion artifacts, aliasing, chemical-shift, zipper, zebra, central point, and truncation artifacts. Although the elimination of some artifacts may require a service engineer, the radiologist and MR technologist have the responsibility to recognize MR imaging problems. This review shows the typical MR appearance of the described artifacts, explains their physical basis, and shows the way to solve them in daily practice.